Skip to main content
. 2021 Feb 10;28(8):4334–4344. doi: 10.1245/s10434-020-09481-8

Table 2.

Clinicopathologic features of intermediate-risk differentiated thyroid cancers (DTCs) at diagnosis

Intermediate-risk DTCs (n = 39)
Features DTCs treated with TT DTCs treated with LT P Value
(n = 27) (n = 12)
Median age at diagnosis: years (range) 47 (15–74) 36.5 (8–70) 0.243
Female/male (%) 23/4 (85/15) 9/3 (75/25) 0.450
Presurgical diagnosis: yes/indeterminate/no (%) 17/2/8 (63/7/30) 7/1/4 (58/8/34) 0.963
Mean size: mm (range) 16.9 (3–47) 17.3 (8–60) 0.910
Histology: FTC/PTC) (%) 2/25 (7/93) 1/11 (8/92) 0.921
Histologic variants of PTC: classical/follicular/other (%) 13/5/7 (52/20/28) 5/3/3 (46/27/27) 0.761
Extrathyroidal invasion: yes/no (%) 11/16 (41/59) 7/5 (58/42) 0.315
Multifocality: yes/no (%) 11/16 (41/59) 2/10 (17/83) 0.146
TNM
 T1/T2/T3/T4 (%) 15/1/11/0 (56/4/40/0) 3/1/7/1 (25/8/59/8) 0.184
 N1/N0/NX (%) 15/3/9 (56/11/33) 8/0/4 (67/0/33) 0.470
 M1/M0 (%) 0/27 (0/100) 0/12 (0/100) 1
AJCC stage (1/2/3/4) 17/0/7/3 (63/0/26/11) 8/0/3/1 (67/0/25/8) 0.959

TT total thyroidectomy, LT lobectomy, FTC follicular thyroid cancer, PTC papillary thyroid cancer, TNM tumor-node-metastasis, AJCC American Joint Committee on Cancer